# Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods

> **NCT02657694** · — · UNKNOWN · sponsor: **FixHepC** · enrollment: 10000 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir+Ledipasvir
- **DRUG:** Sofosbuvir+Daclatasvir
- **DRUG:** Sofosbuvir+Velpatasvir

## Key facts

- **NCT ID:** NCT02657694
- **Lead sponsor:** FixHepC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-01
- **Primary completion:** 2017-01-01
- **Final completion:** 2018-06-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2017-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02657694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02657694, "Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02657694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*